Journal
ACS Bio & Med Chem Au
Publication Date
9-19-2025
Volume
5
Issue
6
First Page
966
Last Page
981
Document Type
Open Access Publication
DOI
10.1021/acsbiomedchemau.5c00158
Rights and Permissions
Berida T, Huang TY, Weck SC, Lutz M, McKee SR, Kagerah N, Manning DL, Jahan ME, Mishra S, Herrmann J, Müller R, Doerksen RJ, Stallings CL, Ducho C, Roy S. 1,2,4-Triazole-Based First-in-Class Non-Nucleoside Inhibitors of the Bacterial Enzyme MraY. ACS Bio Med Chem Au. 2025 Sep 19;5(6):966-981. doi: 10.1021/acsbiomedchemau.5c00158. Berida T, Huang TY, Weck SC, Lutz M, McKee SR, Kagerah N, Manning DL, Jahan ME, Mishra S, Herrmann J, Müller R, Doerksen RJ, Stallings CL, Ducho C, Roy S. 1,2,4-Triazole-Based First-in-Class Non-Nucleoside Inhibitors of the Bacterial Enzyme MraY. ACS Bio Med Chem Au. 2025 Sep 19;5(6):966-981. doi: 10.1021/acsbiomedchemau.5c00158. Copyright © 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY-NC-ND 4.0 .
Recommended Citation
Berida, Tomayo; Huang, Tzu-Yu; Weck, Stefanie C; Lutz, Marcel; McKee, Samuel R; Kagerah, Nathalie; Manning, Destinee L; Jahan, Mohamed E; Mishra, Sushil; Herrmann, Jennifer; Müller, Rolf; Doerksen, Robert J; Stallings, Christina L; Ducho, Christian; and Roy, Sudeshna, "1,2,4-triazole-based first-in-class non-nucleoside inhibitors of the bacterial enzyme MraY." ACS Bio & Med Chem Au. 5, 6. 966 - 981. (2025).
https://digitalcommons.wustl.edu/oa_4/6063
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
